Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ajwain seed extract is a botanical preparation derived from the seeds of *Trachyspermum ammi* (also known as carom or bishop's weed), a plant in the Apiaceae family. The extract is rich in phenolic compounds, most notably thymol, which is responsible for much of its biological activity. In the context of oncology research, ajwain seed extract has demonstrated potent antiproliferative effects against various breast cancer cell lines, including T-47D, MDA-MB-231, and BT-474. Recent studies have explored enhancing its efficacy through acid hydrolysis (to convert glycosides into more active aglycones) and utilizing exosomal delivery platforms, such as bovine milk or colostrum exosomes, to overcome challenges related to poor oral bioavailability and uptake.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ajwain seed extract.